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Kaposi's sarcoma has been described as an opportunistic tumour.
Kaposi's life also reflected a similar facility for self preservation
particularly with his marriage to the daughter of Ferdinand Hebra, the
founder of Vienna's foremost Dermatology Clinic, a clinic of which Kaposi
was later to become the Head. Nevertheless, Moriz Kaposi made major
contributions to venereology and dermatology and his descriptions of the
sarcoma still apply (Kaposi, 1872). Although Kaposi's first patients were
examples of the focal benign form of the sarcoma, he was later to report
progressive systemic involvement. Either type has remained rare in Europe
and of the two the disseminated pattern is the least common(Hutt, 1984).
Ihis is in contrast to Kaposi's sarcoma in central Africa where the tumour
is endemic and invariably disseminated although with some examples
spreading only amongst lyirph nodes (Hutt, 1984). There is a striking
preponderance amongst menand overall the commonest cutaneous site is the
dependent parts of the limbs. Severe oedema is a commonconcomitant.
Microscopically there are proliferating spindle cells separated by vascular
spaces often enclosing red cells (Templeton, 1981). Macroscopically
haemorrhagic lesions are the key to recognition. Distinguishing the
tumour from either inflammatory reactions or vascular neoplasms can at
times be extremely difficult but cytoplasmic eosinophilic inclusions within
sane tumour cells are a unique feature (O'Connell, 1977). Ihe origin of
these inclusions is unclear but the current hypothesis is that they are the
residue of phagocytosed red cells.
A further variant of Kaposi 's sarcoma emerged following the
introduction of organ transplantation for the treatment of end stage renal
disease. The tumour was seen 400-500 times more commonlyamongst graft
recipients than expected (Perm, 1983) (Table 1) and differed in age and sex
distribution, the latter both reflecting the allograft population rather
than any property of the tumour. Although the localised and the
disseminated form occurred there was often an overlap between the two with
a mixed pattern predominating. This phenomenon is repeated amongst AIDS
sufferers where the tumour has an even higher incidence (Fauci, 1984)
(Table 1).
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TABLE I TOMOTiRS(%) and IMMJN3DEFICIENCY
Kaposi's sarcoma is an integral part of the definition of AIDS and its
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distribution amongst these patients in Europe mimics that in the United
States (CDC, 1985; CDC, 1986) (Table 2). ohus in Europe isolated
Kaposi's sarcoma provides the second form of presentation and patients with
Kaposi^s sarcoma alone have a longer life expectancy than those with
infection, accompanied or unaccompanied by tumour. In either environment
it is often unclear exactly how the tumour contributes to death.
Opportunistic infection

















THE POLE OF IMMUNODEFICIENCY
A link between Kaposi's sarcoma in transplant recipients and in those
with AIDS is immunodeficiency. This is predominantly a cellular defect
with an emphasis on a reduction of the T-helper cells. Lasting regression
of the tumour has resulted amongst transplant recipients when
immunoccmpetence is restored (Perm, 1983) but since a similar manipulation
is not possible in AIDS, equivalent regression has yet to be recorded.
Depressed cellular responses have been found amongst Africans with Kaposi 's
sarcoma although not uniformly (Kestens et al, 1985) and there is
spontaneous regression in both the sporadic and endemic forms of the
disorder (Templeton, 1981). A commonphenotype is shared by those with
the spontaneous disease and by some homosexuals with AIDS (Friedman-Kien et
al, 1982) but this has not been described within the allografted patients.
The development of the tumour in the T-regions of lymph nodes and the
appearance of lyirphomas amongst these patients ( Ziegler et al, 1984) may
also be pointers towards a role for the immune system. The sarcoma most
often appears either simultaneously with the lyrnphoma or following its
recognition (Safai et al, 1980) and at either of these times
immunodepression is probably established.
If immunodeficiency is important in the pathogenesis of Kaposi's
sarcoma the marked variation in the incidence of this tumour amongst the
immunodeficient population (Table 1) has to be explained. The tumour has
neither been recognised amongst the primary immunodeficiency syndromes nor
amongst those with secondary immunodeficiency other than that following
allografting or AIDS. Secondary immunodeficiency is however poorly
reported. The absence in primary and most secondary imiunodeficiency
could relate to these patients' short life span although the tumour appears
on average sixteen and a half months after grafting and has developed
within two and a half months (Penn, 1983). The life span of those with
primary immunodeficiency is nevertheless sufficient for the growth of
lymphomas (Frizzera et al, 1980) and the variation between the incidence of
lymphonas and Kaposi's sarcoma amongst the graft and AIDS patients (Table
1) cannot be clearly explained either in terms of life expectancy or
immunodeficiency.
An alternate or related pathogenic factor is persistent antigenic
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stimulation. This may either produce immunodeficiency so permitting
tumour expression or be directly involved in tumour genesis. Chronic
malaria is the antigen specifically incriminated in Kaposi's sarcoma in
Africa (Hutt, 1984) and donor antigens in those with grafts (Penn, 1983).
The multiple infections experienced by AIDS patients may individually or
collectively have a role but especial attention has been directed to the
cytomegalovirus (CMV) (Giraldo, Beth and Huang, 1980).
THE ROLE OF INFECTION
An association between CMVand Kaposi's sarcoma is a distinct
possibility (Giraldo, Beth and Huang, 1980). -ttiere is a high frequency of
CMVin allografted and many AID6 patients, populations both subject to
Kaposi's sarcoma. A similar high rate of infection is however found
within the entire population of the United Kingdom but without any
increased risk of Kaposi's sarcoma. The demonstration of CMV-DNAand RNA
in Kaposi tumour cells strengthened the possibility of a relationship
(Giraldo, Beth and Huang, 1980) until it was appreciated that honologies
existed between the genomes of CMVand human DNA(Peden, Mounts and
Hayward, 1982). Preliminary studies incorporating specific viral EWA
fragments failed to reveal CMV-DNAsequences in Kaposi tumours. The place
of CMVin the aetiology of Kaposi's sarcoma therefore remains unproven.
There is no reason to suppose that either the Epstein-Barr or the
Hepatitis B viruses, both potential oncogenic agents and commonly found in
many with Kaposi's sarcoma (Penn, 1983; Fauci, 1984) , are involved in this
tumour's formation. HTLVIII/LAV although widespread in Africa and the
commondenominator to those with AIDS is similarly unrelated.
Nevertheless, despite the failure to identify a putative agent there are
observations which suggest some forms of Kaposi 's sarcoma may indeed be
infective. The striking localisation of the tumour in Central Africa
(Hutt, 1984) is the most convincing. Further support comes fron the
restriction of the tumour to the indigenous populations of these regions
and the absence amongst immigrants from and to these areas. The high
incidence of Kaposi's sarcoma in AIDS is a further factor (CDC, 1986).
THE CELL OF ORIGIN
Ignorance of the cause of Kaposi's sarcoma mirrors the confusion over
the cell of origin. A wide range of cells has been incriminated mainly
relying upon electron microscopy studies (Templeton, 1981). Many of these
cells are commonto the tissues in which the tumour is found and there is
no conclusive evidence that any one is the stem cell. The present
hypothesis is that the tumour arises from vascular endothelium although in
none of the studies were Weibel-Palade bodies, the ultrastructural marker
of vascular endothelium, found. The gross and microscopic appearances
have clear analogies with vascular tumours and immunocytological studies
incorporating peroxidase labelling and polyclonal Factor VIII related
antigen (FVIIIRA) may provide evidence in support of this concept (Millard
and Heryet, 1985). A smaller number of studies using lectins are
similarly supportive (Ordonez and Batsakis, 1984). The peroxidase studies
include reports of staining confined to the cells lining the spaces within
the tumour and of staining of the intervening spindle cells (Millard and
Heryet, 1985). The results are inconsistent and this in part may have
arisen from variations in technique. Commercially obtainable polyclonal
antibodies were used and these can vary in their specificity and purity.
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Different fixatives as well as enzyme digestion were other variables but
conmonto most studies was the absence of a clear description of what
constituted positive staining. Background staining with this antibody is
often difficult to eliminate and can obviously provide a source of observer
error. False positivity can also arise from the use of Freund's adjuvant
in the preparation of polyclonal antibodies if the tissues under study
include mycobacteria (Kahn et al, 1985) (Fig 1). This potential cross
reactivity may apply particularly to AIDS patients infected with atypical
mycobacteria. Further, FVIIIRA is not confined to endothelial cells but
occurs in a range of other cells (Millard and Heryet, 1985) many of which
are found in the skin, the most commonlystudied tissue. Staining of
cells other than tumour cells is therefore possible. Conversely, not all
endothelial cells even within normal tissues display the antigen and absent
staining does not prove that a cell is not endothelial. The protein forms
part of the plasma and if cryostat tissue is used, this and the
haemorrhagic component of the tumour contribute to diffuse staining.
Enzyme digestion can in turn add to difficulties in antigen demonstration
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FIGURE 1 Mediastinal lymph node exposed to polyclonal FVIIIRA.
There is positive staining of the endothelium of the vessel
(right) and of the macrophages within the lymph node (left)
The mcrophages included large numbers of Mycobacteria.
The patient was a homosexual with AIDS.
Diaminobenzidine x 320.
In an attempt to resolve these difficulties we studied six Kaposi's
sarcomas with two commercially obtainable polyclonal antibodies and four
monoclonal antibodies to FVIIIRA all with and without trypsin and protease
(Millard and Heryet, 1985). Positive labelling of tumour cells was only
accepted when it matched that in labelled endothelial cells in vessels
unrelated to the tumour. Acceptable and reproducible staining was
provided by both type of antibody (Fig 2). Within the tumour staining was
confined to some cells lining the spaces and was absent within the
intervening spindle cells, a result that was consistent with all previous
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Kaposi 's sarcoma stained with
monoclonal FVIIIRA. The
endothelial cells lining the
vessels are stained but none
of the intervening spindle
cells.
Diaminobenzidine x 400.
The view that Kaposi's sarcoma arises from vascular endothelium is not
firmly substantiated and attention has now reverted to the possibility of
an origin from lynphatic endothelium (Dorfman, 1984). The lymphoedema
frequently found with the tumour and the earliest histological appearances
when the spindle cell component is sparsely represented are compatible with
the idea as is the rarity of Kaposi's sarcoma within the brain (Templeton,
1981) , an organ devoid of lymphatics. Histochemical studies too provide
some support for this viewpoint (Beckstead, Wood and Fletcher, 1986).
Monoclonal antibodies to lymphatic endothelium have been used in a study of
early and late lesions and the results also suggested that the cell of
origin is from lymphatic endothelium (Jones et al, 1986). The study,
however, largely depended upon a single monoclonal antibody, not unique to
lymphatic endothelium, and panels of these antibodies are to be preferred
before conclusive claims are made.
CONCLUS ION
Kaposi's sarcoma remains an enigma. Despite the appearance of AIDS
and the increased number of examples for study there is still uncertainty
over the role of the iinmune responses, the role of infective agents,
especially cytomegalovirus, and the cell of origin. The striking male
predominance, highlighted in AIDS, and yet absent amongst haemophiliacs
with AIDS is also unexplained.
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